• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

AVEO Pharmaceuticals Inc

+ Add to Watchlist

VPA:GR

0.681 EUR 0.023 3.27%

As of 02:08:45 ET on 12/22/2014.

Snapshot for AVEO Pharmaceuticals Inc (VPA)

Open: 0.681 Day's Range: 0.681 - 0.689 Volume: 0
Previous Close: 0.704 52wk Range: 0.460 - 1.487 1-Yr Rtn: -43.25%

Stock Chart for VPA

No chart data available.
  • VPA:GR 0.681
  • 1D
  • 1M
  • 1Y
0.704
Interactive VPA Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for VPA

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) -0.9600
Est. PEG Ratio -
Market Cap (M EUR) 35.59
Shares Outstanding (M) 52.26
30 Day Average Volume 1,406
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 03/13/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for VPA

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for VPA

Aveo Pharmaceuticals Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing cancer therapeutics. The Company's lead product candidate is an oral inhibitor of the vascular endothelial growth factor, or VEGF,receptors.

Tuan Ha-NgocPresident/CEO/Acting CFOJeno GyurisChief Scientific Officer
Michael P BaileyChief Business OfficerJoseph VittiglioSenior VP/General Counsel
More Company Profile & Key Executives for VPA

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
  • VPA News

  • Industry News

Advertisement
Sponsored Links
Advertisements
sec ||= nil